Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence

Maladjusted immune responses to the coronavirus disease 2019 (COVID-19), for example, cytokine release syndrome, may result in immunopathology and acute respiratory distress syndrome. Sphingosine-1-phosphate (S1P), a bioactive lipid mediator, and its S1P receptor (S1PR) are crucial in maintaining en...

Descripción completa

Detalles Bibliográficos
Autores principales: Hach, Thomas, Shakeri-Nejad, Kasra, Bigaud, Marc, Dahlke, Frank, de Micco, Massimiliano, Petricoul, Olivier, Graham, Gordon, Piani-Meier, Daniela, Turrini, Renato, Brinkmann, Volker, Nicoletti, Ferdinando
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc., publishers 2023
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282791/
https://www.ncbi.nlm.nih.gov/pubmed/36454249
http://dx.doi.org/10.1089/jir.2022.0078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282791/
https://www.ncbi.nlm.nih.gov/pubmed/36454249
http://dx.doi.org/10.1089/jir.2022.0078

Ejemplares similares